LINC01456: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Target Name: LINC01456

NCBI ID: G105373144

LINC01456

Other Name(s): long intergenic non-protein coding RNA 1456 | Long intergenic non-protein coding RNA 1456

LINC01456: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Introduction

LINC01456 is a long intergenic non-protein coding RNA (lncRNA) that has been identified in various studies as having potential drug targets or biomarkers. This RNA is located between the genes HO-1 and ID0 in chromosome 6 and is highly expressed in various tissues , including the brain, heart, and liver. The function and regulation of LINC01456 are still poorly understood, but its potential role in disease progression and drug resistance have generated a lot of interest in recent years.

Drug Targets

LINC01456 has been predicted to have several potential drug targets due to its unique structure and location in the genome. One of the predicted drug targets is the protein kinase PDK4, which is known to play a role in cell signaling and metabolism. The interaction between PDK4 and LINC01456 has been reported in various studies, suggesting that LINC01456 may be a potential drug target for PDK4 inhibitors.

Another predicted drug target of LINC01456 is the transcription factor SPYRNA-6, which is known to regulate gene expression and has been implicated in various diseases, including cancer. The interaction between LINC01456 and SPYRNA-6 has also been reported, suggesting that LINC01456 may be a potential drug target for SPYRNA-6 inhibitors.

Biomarkers

LINC01456 has also been predicted to have potential as a biomarker for various diseases, including cancer, cardiovascular disease, and neurodegenerative diseases. The expression of LINC01456 has been correlated with the severity of various diseases, including cancer, suggesting that it may be a useful biomarker for monitoring disease progression.

The expression of LINC01456 has also been correlated with the expression of genes involved in cell signaling and metabolism, which are known to be involved in various diseases, including cancer. This suggests that LINC01456 may be a potential biomarker for cancer, and that its expression levels may be used as a diagnostic tool for cancer.

Conclusion

In conclusion, LINC01456 is a long intergenic non-protein coding RNA that has potential as a drug target or biomarker. Its unique structure and location in the genome, as well as its predicted drug targets and biomarkers, make it an attractive target for further research . Further studies are needed to fully understand the function and regulation of LINC01456 and its potential as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1456

The "LINC01456 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01456 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets